Jenburkt Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 382.89 million compared to INR 358.52 million a year ago. Revenue was INR 393.85 million compared to INR 371.14 million a year ago. Net income was INR 73.22 million compared to INR 68.66 million a year ago. Basic earnings per share from continuing operations was INR 16.59 compared to INR 14.96 a year ago.
For the six months, sales was INR 674.65 million compared to INR 669.84 million a year ago. Revenue was INR 695.97 million compared to INR 693.88 million a year ago. Net income was INR 126.91 million compared to INR 128.19 million a year ago. Basic earnings per share from continuing operations was INR 28.76 compared to INR 27.93 a year ago.